The use of ezpap in patients with Covid-19 pneumonia and multiple sclerosis

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of Experimental and Clinical Medicine
Volume:39 Issue:2
The use of ezpap in patients with Covid-19 pneumonia and multiple sclerosis

The use of ezpap in patients with Covid-19 pneumonia and multiple sclerosis

Authors : Esma Sevil AKKURT, Tuğçe ŞAHİN ÖZDEMİREL, Özlem ERTAN, Berna AKINCI ÖZYÜREK

Pages : 551-553

View : 54 | Download : 7

Publication Date : 2022-03-18

Article Type : Other Papers

Abstract :Abstract In patients with multiple sclerosis insert ignore into journalissuearticles values(MS); respiratory muscle weakness and related development of respiratory failure are important causes of mortality. Complications such as atelectasis and susceptibility to respiratory infections are common in these patients. In cases of atelectasis and hypoxemia that develop due to the weakness of inspiratory muscles, the use of EzPAP® positive airway pressure therapy system should also be kept in mind, in addition to nasal oxygen and NIMV treatment options. In this case, we aimed to present our patient with the diagnosis of MS who was followed up for severe Covid 19 pneumonia and for whom EzPAP® positive airway pressure therapy system was used for treatment.
Keywords : Multiple sclerosis, COVID 19, EzPAP®

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.